Liraglutide Injection 18?mg/3?ml Prefilled Pen | Tonboli by Tonghua Dongbao |

描述

 Description

Product name: Liraglutide injection (Tongboli/Dongbao)
Packaging specifications: Pre-filled 3ml:18mg ? Product dosage form: injection ? Packaging unit: stick/box
Approval number: National Medicine Standard S20230066 ? Drug code: 86903546001121
Manufacturer: Tonghua Dongbao Pharmaceutical Co., Ltd.

Liraglutide Injection (Tonboli) is a domestically manufactured GLP?1 receptor agonist and the second Chinese-made solution approved for type 2 diabetes treatment. Developed as a biosimilar to Novo Nordisk’s Victoza®, it received regulatory approval under NMPA S20230066 in December 2023?.

• Active Ingredient: Liraglutide, a 97% human GLP?1 analog peptide

• Formulation: 18?mg of liraglutide in 3?ml of isotonic, clear solution with stabilizers and phenol?

• Delivery: Single-dose, prefilled auto-injector pen

• Source: Approved by NMPA, produced by Tonghua Dongbao?

This innovative biodrug is a key addition to China’s growing family of GLP?1RAs, enabling research into glucose regulation, weight control, cardiovascular effects, and peptide-based therapy mechanisms?.

 Product Specifications

 Mechanism & Clinical Data

• GLP?1 receptor activation promotes insulin secretion, suppresses glucagon, and slows gastric emptying?.

• Approved for glycaemic control in adults with T2DM; Tonboli represents China’s second domestic GLP?1RA?.

• Tonghua Dongbao continues advancing its GLP?1 pipeline, including semaglutide and GLP?1/GIP dual agonists?.

• International rollout is supported through cooperation with Sinovac in emerging markets?.

? Why Choose Tonboli Liraglutide?

• ? Research-grade GLP?1RA with reliable production

• ?? NMPA-approved and China-manufactured, ensuring traceability

• ? Prefilled pen offers precise dosing for studies

• ? Supports robust metabolic, peptide pharmacokinetics, and cardiovascular research pipelines

? Related Research Agents

• Semaglutide Injection (Ozempic®) – GLP?1 RA

• Dual GLP?1/GIP Agonist Peptide Pharmaceuticals

• Sitagliptin – DPP?4 Inhibitor Tablets

• Empagliflozin – SGLT?2 Inhibitor Tablets

? Summary

Tonboli Liraglutide 18?mg/3?ml prefilled pen is a domestically approved GLP?1RA suitable for research into metabolic and cardiovascular pathways. With high regulatory confidence, peptide-level precision, and prefilled format, it’s well-suited for academic and lab settings.
?? Strictly for laboratory research or analytical use only — not for human consumption or therapy.